[go: up one dir, main page]

IN2013MU03611A - - Google Patents

Info

Publication number
IN2013MU03611A
IN2013MU03611A IN3611MU2013A IN2013MU03611A IN 2013MU03611 A IN2013MU03611 A IN 2013MU03611A IN 3611MU2013 A IN3611MU2013 A IN 3611MU2013A IN 2013MU03611 A IN2013MU03611 A IN 2013MU03611A
Authority
IN
India
Prior art keywords
composition
relates
budesonide
salts
solid oral
Prior art date
Application number
Inventor
Ajmal Shareef
Ananda Haranath Uppala
Rahul Sudhakar Dabre
Girish Kumar Jain
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2014/065914 priority Critical patent/WO2015071812A1/en
Priority to IN3611MU2013 priority patent/IN2013MU03611A/en
Publication of IN2013MU03611A publication Critical patent/IN2013MU03611A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a process of preparing solid oral modified-release composition comprising budesonide or salts thereof. In particular, the present invention relates to solid oral modified-release composition comprising matrix of budesonide or salts thereof with one or more lipophilic excipients and one or more hydrophilic excipients comprising polymers having low viscosity, and the composition is free of any amphiphilic excipient. The invention further relates to use of such composition in the treatment of ulcerative colitis.
IN3611MU2013 2013-11-18 2014-11-10 IN2013MU03611A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2014/065914 WO2015071812A1 (en) 2013-11-18 2014-11-10 Solid oral modified-release composition comprising budesonide or salt thereof
IN3611MU2013 IN2013MU03611A (en) 2013-11-18 2014-11-10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3611MU2013 IN2013MU03611A (en) 2013-11-18 2014-11-10

Publications (1)

Publication Number Publication Date
IN2013MU03611A true IN2013MU03611A (en) 2015-07-31

Family

ID=54397597

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3611MU2013 IN2013MU03611A (en) 2013-11-18 2014-11-10

Country Status (1)

Country Link
IN (1) IN2013MU03611A (en)

Similar Documents

Publication Publication Date Title
ZA201708692B (en) Antibacterial compounds
WO2015160975A3 (en) Combination of a pi3k inhibitor with a bcl-2 inhibitor for use in the treatment of cancer
PH12017500315A1 (en) Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection
CL2015002897A1 (en) Bace1 inhibitors
MX2017012596A (en) A pharmaceutical composition and the use thereof.
MX2019000677A (en) B-cell-mimetic cells.
PH12017501071B1 (en) Dihydropyrimidin-2-one compounds and medical use thereof
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
WO2017079403A3 (en) Polymeric nanoparticles
GB2527233A (en) Composition comprising hydrocortisone
MX2015013755A (en) Pharmaceutical formulation for use in the treatment and/or prevention of restenosis.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2017007027A (en) Low dosage a2a antagonist for the treatment of adhd and parkinsons.
MX2020006075A (en) Bendamustine pharmaceutical compositions.
WO2015044434A3 (en) Fluor-9-methyl-β-carbolines
IN2013MU02576A (en)
IN2013MU03667A (en)
IN2013MU03611A (en)
IN2013MU03668A (en)
IN2013MU03612A (en)
WO2016137266A3 (en) Pharmaceutical composition containing eperisone and pelubiprofen
RU2014154366A (en) APPLICATION OF THE PROBIOTIC STRAIN OF THE MICROOORGANISM ENTEROCOCCUS FAECIUM L3 FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
IN2013MU03855A (en)